ATE458070T1 - Verfahren und zusammensetzungen zur analyse von urinproben bei der diagnose und behandlung von nierenerkrankungen - Google Patents

Verfahren und zusammensetzungen zur analyse von urinproben bei der diagnose und behandlung von nierenerkrankungen

Info

Publication number
ATE458070T1
ATE458070T1 AT03745632T AT03745632T ATE458070T1 AT E458070 T1 ATE458070 T1 AT E458070T1 AT 03745632 T AT03745632 T AT 03745632T AT 03745632 T AT03745632 T AT 03745632T AT E458070 T1 ATE458070 T1 AT E458070T1
Authority
AT
Austria
Prior art keywords
urinary tract
methods
urine samples
compositions
diagnosis
Prior art date
Application number
AT03745632T
Other languages
English (en)
Inventor
David Kurnit
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE458070T1 publication Critical patent/ATE458070T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03745632T 2002-03-28 2003-03-27 Verfahren und zusammensetzungen zur analyse von urinproben bei der diagnose und behandlung von nierenerkrankungen ATE458070T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/108,969 US20030198959A1 (en) 2002-03-28 2002-03-28 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
PCT/US2003/009389 WO2003082202A2 (en) 2002-03-28 2003-03-27 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases

Publications (1)

Publication Number Publication Date
ATE458070T1 true ATE458070T1 (de) 2010-03-15

Family

ID=28673613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745632T ATE458070T1 (de) 2002-03-28 2003-03-27 Verfahren und zusammensetzungen zur analyse von urinproben bei der diagnose und behandlung von nierenerkrankungen

Country Status (14)

Country Link
US (1) US20030198959A1 (de)
EP (1) EP1578357B1 (de)
JP (2) JP4447328B2 (de)
CN (1) CN1863923B (de)
AT (1) ATE458070T1 (de)
AU (2) AU2003258080A1 (de)
BR (1) BR0308808A (de)
CA (1) CA2479379A1 (de)
DE (1) DE60331353D1 (de)
HK (1) HK1079127A1 (de)
IL (1) IL164098A0 (de)
MX (1) MXPA04009436A (de)
WO (1) WO2003082202A2 (de)
ZA (1) ZA200407457B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063090A1 (de) * 2005-11-30 2007-06-07 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung der ureterabgangsstenose
WO2008084331A2 (en) * 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
US20090068683A1 (en) * 2007-06-11 2009-03-12 Mayo Foundation For Medical Education And Research Markers for preeclampsia
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
WO2009059259A2 (en) * 2007-10-31 2009-05-07 Children's Hospital Medical Center Detection of worsening renal disease in subjects with systemic lupus erythematosus
EP2304437A4 (de) * 2008-07-22 2012-06-20 Siemens Healthcare Diagnostics Krankheitsspezifische diagnosehilfe
AU2010339723B2 (en) * 2009-12-21 2014-11-06 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-VEGF treatment
TW201250248A (en) * 2011-04-25 2012-12-16 Kyowa Medex Co Ltd Prognostication method of renal failure
EP2702998A1 (de) 2012-08-31 2014-03-05 IMBA-Institut für Molekulare Biotechnologie GmbH Therapeutischer und diagnostischer miRNA-Regulator der Nierenkrankheit
JP2016512698A (ja) * 2013-03-15 2016-05-09 イムコア ジーティーアイ ダイアグノスティクス インコーポレイテッド 尿中セルフリーｄｎａを用いて腎状態を評価するための方法および組成物
CN104502596A (zh) * 2014-12-23 2015-04-08 温州医科大学 一种慢性肾病诊断试剂盒
WO2018177949A1 (en) * 2017-03-25 2018-10-04 Charité-Universitätsmedizin Berlin Urine flow cytometry as biomarker of renal diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US20020184655A1 (en) * 1997-12-01 2002-12-05 Henryk Lubon Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
EP1055684A4 (de) * 1997-12-05 2002-12-04 Kyogo Itoh Tumorantigene in form von peptidderivaten
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
FI991369A0 (fi) * 1999-06-15 1999-06-15 Harry Holthoefer Haiman ja munuaiskeräsen ilmentäminen liukoisten proteiinimolekyylien käyttö
WO2000079280A1 (fr) * 1999-06-22 2000-12-28 Japan As Represented By Director-General National Institute Of Infectious Diseases Materiel de detection de srsv
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20030190624A1 (en) * 2002-03-26 2003-10-09 Chao Zhang Genes expressed with high specificity in kidney

Also Published As

Publication number Publication date
BR0308808A (pt) 2005-11-22
AU2009200813A8 (en) 2009-04-09
ZA200407457B (en) 2005-08-31
MXPA04009436A (es) 2005-07-05
JP2009207496A (ja) 2009-09-17
WO2003082202A3 (en) 2006-03-23
CN1863923A (zh) 2006-11-15
WO2003082202A2 (en) 2003-10-09
US20030198959A1 (en) 2003-10-23
JP2005534892A (ja) 2005-11-17
EP1578357A2 (de) 2005-09-28
CA2479379A1 (en) 2003-10-09
HK1079127A1 (en) 2006-03-31
IL164098A0 (en) 2005-12-18
JP4447328B2 (ja) 2010-04-07
CN1863923B (zh) 2011-06-29
EP1578357A4 (de) 2007-11-28
DE60331353D1 (de) 2010-04-01
EP1578357B1 (de) 2010-02-17
AU2003258080A1 (en) 2003-10-13
AU2009200813A1 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
HK1079127A1 (en) Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
NO20050186D0 (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
MXPA05007063A (es) Aparato para la fabricacion de dispositivos medicos.
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
NO20030251L (no) Fremgangsmåte for differensiering mellom biologiske tilstander basert på skjulte mönstre fra biologiske data
WO2004058044A3 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
EA200701602A1 (ru) Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича
EP2322531A3 (de) Methoden für die diagnose von demenz und anderen neurologischen erkrankungen
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
ZA951526B (en) Method of diagnosing cancer precancerous state or susceptibility to other forms of diseases by analysis or IRF-1-specific RNA in biopsy samples
CN102859357A (zh) 肾脏病诊断用标志物及其利用
Chai et al. STROBE: the correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
DK1043587T3 (da) Fremgangsmåde til undersøgelse af nyresygdomme
EP1698898A3 (de) Prognostische, diagnostische und therapeutische Signifikanz beim Nachweis und der Verwendung von TIN-Antigen (Tubulointerstitielle Nephritis-Antigen) und seinen Segmenten
ATE309542T1 (de) Verwendung der glycin-n-acyl-transferase (gnat) für die diagnose von entzündungserkrankungen und sepsis
JP2006509500A5 (de)
CA2836656C (en) Disease detection by digital protein truncation assays
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
CN108384848B (zh) 血清中circ_0021132作为深静脉血栓形成诊断标志物的应用
JP2005168474A (ja) ヘリコバクター・ピロリ菌のクラリスロマイシン耐性検査方法
Jenosha et al. Vancomycin resistance in Enterococcus isolates from clinical samples received at the Microbiology Laboratory, Teaching Hospital Jaffna
WO2006001544A1 (ja) 新規な味覚異常検査法
Adetunji et al. Procedures for sampling of small and larger samples of microbiome
US20240002954A1 (en) Evaluation method for bisulfite reagent and genetic test method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties